Alkeon Capital Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-200,222
| Closed | -$9.9M | – | 94 |
|
|
2023
Q3 | $9.9M | Hold |
200,222
| – | – | 0.02% | 74 |
|
|
2023
Q2 | $15.7M | Hold |
200,222
| – | – | 0.03% | 77 |
|
|
2023
Q1 | $18.1M | Hold |
200,222
| – | – | 0.04% | 74 |
|
|
2022
Q4 | $23.6M | Sell |
200,222
-13,826
| -6% | -$1.63M | 0.09% | 76 |
|
|
2022
Q3 | $38.8M | Buy |
214,048
+94,313
| +79% | +$17.1M | 0.13% | 74 |
|
|
2022
Q2 | $10.7M | Buy |
119,735
+86,956
| +265% | +$7.8M | 0.03% | 93 |
|
|
2022
Q1 | $5.09M | Sell |
32,779
-526
| -2% | -$81.7K | 0.01% | 109 |
|
|
2021
Q4 | $9.91M | Sell |
33,305
-14,239
| -30% | -$4.24M | 0.02% | 121 |
|
|
2021
Q3 | $27.4M | Hold |
47,544
| – | – | 0.05% | 107 |
|
|
2021
Q2 | $21.6M | Sell |
47,544
-152
| -0.3% | -$69K | 0.03% | 109 |
|
|
2021
Q1 | $25.7M | Hold |
47,696
| – | – | 0.04% | 100 |
|
|
2020
Q4 | $42.2M | Hold |
47,696
| – | – | 0.07% | 92 |
|
|
2020
Q3 | $30.2M | Buy |
+47,696
| New | +$30.2M | 0.06% | 94 |
|